Company Analysis
Sign in

Natera, Inc. (NTRA)

Nasdaq: NTRA · Services-Medical Laboratories · Austin, TX · filing with the SEC since 2014
Full chart Alerts Compare
Grade6.6
◀ Past 5.8● Present 6.5▶ Future 7.5
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

108 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Natera, Inc.’s names, not what it holds today.

Patents granted
108
108 utility, 1976 to Dec 31, 2025
Granted in 2025
18
Against 11 in 2024 and 1 in 2023
Applications published
244
20 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology43
Computer technology14
Chemical engineering2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Natera, Inc. its own name
US, as the owner printed on each patent
108 granted
236 published
Natera, Inc. its own name
named as the applicant on its applications, in US
0 granted
8 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 30, 202512,509,730Methods for simultaneous amplification of target lociBiotechnologyNatera, Inc.
Dec 30, 202512,509,728System and method for cleaning noisy genetic data and determining chromosome copy numberBiotechnologyNatera, Inc.
Dec 9, 202512,494,267Methods for non-invasive prenatal ploidy callingBiotechnologyNatera, Inc.
Dec 9, 202512,492,429Detecting mutations and ploidy in chromosomal segmentsBiotechnologyNatera, Inc.
Dec 2, 202512,486,542Detecting mutations and ploidy in chromosomal segmentsComputer technologyNatera, Inc.
Nov 4, 202512,460,264Method of detecting tumour recurrenceBiotechnologyNatera, Inc.
Sep 9, 202512,410,476Methods for simultaneous amplification of target lociBiotechnologyNatera, Inc.
Aug 26, 202512,398,389Methods for isolating nucleic acids with size selectionBiotechnologyNatera, Inc.
Aug 12, 202512,385,096Methods for cancer detection and monitoringBiotechnologyNatera, Inc.
May 20, 202512,305,235Methods for detecting immune cell DNA and monitoring immune systemBiotechnologyNatera, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 25, 20252025/0391576METHODS FOR PREDICTING AND SELECTING NEOANTIGENSComputer technologyNatera, Inc.
Dec 25, 20252025/0388956COMPOSITIONS AND METHODS FOR IDENTIFICATION OF CHROMOSOMAL MICRODELETIONSBiotechnologyNatera, Inc.
Oct 23, 20252025/0329411METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLINGBiotechnologyNatera, Inc.
Aug 14, 20252025/0257405METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCIBiotechnologyNatera, Inc.
Jul 10, 20252025/0226093PREDICTIVE MACHINE LEARNING MODELS FOR PREECLAMPSIA USING ARTIFICIAL NEURAL NETWORKSMedical technologyNatera, Inc.
Jul 10, 20252025/0223654DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTSComputer technologyNatera, Inc.
May 29, 20252025/0174301METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLINGBiotechnologyNatera, Inc. · patent 12,494,267 granted from it
May 29, 20252025/0171859DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTSComputer technologyNatera, Inc.
May 29, 20252025/0171850METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCIBiotechnologyNatera, Inc.
May 22, 20252025/0163516DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTSComputer technologyNatera, Inc.
What it applied for, 2024 to 2025: Biotechnology 42 · Computer technology 11 · Chemical engineering 1 · Medical technology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton NTRA · research, not advice